• An airway mucus regulator with anti-inflammatory action
• Unique approach involves several points of attack in obstructive airway disease
• Contains ambroxol, which facilitates various steps in the biosynthesis of pulmonary surfactant, theophylline-7 acetic acid whoose carrier function raises blood level of ambroxol, thus rapidly and intensely simulating surfactant production
• The resulting reduction in the viscosity and adhesivity of the mucus greatly improves ciliary clearance
• Improves symptoms like cough intensity, frequency, dyspnea, cyanosis, difficulty of expectoration & sputum quantity
• Clinical studies show good tolerability with high safety profile
